AstraZeneca PLC (AZN) - Total Liabilities

Latest as of March 2026: GBX66.63 Billion GBX ≈ $8.11 Million USD

Based on the latest financial reports, AstraZeneca PLC (AZN) has total liabilities worth GBX66.63 Billion GBX (≈ $8.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore AstraZeneca PLC equity growth rate to track the company's year-over-year net asset growth rate.

AstraZeneca PLC - Total Liabilities Trend (1990–2025)

This chart illustrates how AstraZeneca PLC's total liabilities have evolved over time, based on quarterly financial data. See AZN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

AstraZeneca PLC Competitors by Total Liabilities

The table below lists competitors of AstraZeneca PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Odfjell Drilling Ltd OL:ODL	Norway	Nkr1.25 Billion
Insignia Financial Ltd AU:IFL	Australia	AU$1.70 Billion
Pengxin International Mining Co Ltd SHG:600490	China	CN¥1.77 Billion
MOBVISTA INC. DL-01 F:6MO	Germany	€587.56 Million
Xuzhou Handler Special Vehicle Co Ltd SHE:300201	China	CN¥947.07 Million
Pandox AB (publ) ST:PNDX-B	Sweden	Skr78.83 Billion
LEROY SEAFOOD GR.UNSP.ADR F:Z1L0	Germany	€20.77 Billion
Ningbo ZhongDa Leader Intelligent Transmission Co Ltd SHE:002896	China	CN¥649.06 Million

Liability Composition Analysis (1990–2025)

This chart breaks down AstraZeneca PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AstraZeneca PLC (AZN) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AstraZeneca PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AstraZeneca PLC (1990–2025)

The table below shows the annual total liabilities of AstraZeneca PLC from 1990 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX65.36 Billion ≈ $7.95 Million	+3.47%
2024-12-31	GBX63.16 Billion ≈ $7.69 Million	+1.95%
2023-12-31	GBX61.95 Billion ≈ $7.54 Million	+4.25%
2022-12-31	GBX59.42 Billion ≈ $7.23 Million	-10.07%
2021-12-31	GBX66.08 Billion ≈ $8.04 Million	+29.33%
2020-12-31	GBX51.09 Billion ≈ $6.22 Million	+9.21%
2019-12-31	GBX46.78 Billion ≈ $5.69 Million	+0.37%
2018-12-31	GBX46.61 Billion ≈ $5.67 Million	-0.22%
2017-12-31	GBX46.71 Billion ≈ $5.68 Million	+1.86%
2016-12-31	GBX45.86 Billion ≈ $5.58 Million	+10.19%
2015-12-31	GBX41.62 Billion ≈ $5.06 Million	+6.84%
2014-12-31	GBX38.95 Billion ≈ $4.74 Million	+19.31%
2013-12-31	GBX32.65 Billion ≈ $3.97 Million	+10.36%
2012-12-31	GBX29.58 Billion ≈ $3.60 Million	+0.76%
2011-12-31	GBX29.36 Billion ≈ $3.57 Million	-10.27%
2010-12-31	GBX32.72 Billion ≈ $3.98 Million	-4.05%
2009-12-31	GBX34.10 Billion ≈ $4.15 Million	+10.39%
2008-12-31	GBX30.89 Billion ≈ $3.76 Million	-6.51%
2007-12-31	GBX33.04 Billion ≈ $4.02 Million	+127.62%
2006-12-31	GBX14.52 Billion ≈ $1.77 Million	+30.20%
2005-12-31	GBX11.15 Billion ≈ $1.36 Million	-0.05%
2004-12-31	GBX11.15 Billion ≈ $1.36 Million	+8.13%
2003-12-31	GBX10.32 Billion ≈ $1.26 Million	-0.38%
2002-12-31	GBX10.36 Billion ≈ $1.26 Million	+16.78%
2001-12-31	GBX8.87 Billion ≈ $1.08 Million	-0.34%
2000-12-31	GBX8.90 Billion ≈ $1.08 Million	-6.04%
1999-12-31	GBX9.47 Billion ≈ $1.15 Million	+26.33%
1998-12-31	GBX7.50 Billion ≈ $912.05K	+60.91%
1997-12-31	GBX4.66 Billion ≈ $566.80K	-4.95%
1996-12-31	GBX4.90 Billion ≈ $596.33K	+1.40%
1995-12-31	GBX4.83 Billion ≈ $588.09K	+5.23%
1994-12-31	GBX4.59 Billion ≈ $558.87K	-9.94%
1993-12-31	GBX5.10 Billion ≈ $620.56K	-15.25%
1992-12-31	GBX6.02 Billion ≈ $732.24K	+10.52%
1991-12-31	GBX5.45 Billion ≈ $662.52K	+0.49%
1990-12-31	GBX5.42 Billion ≈ $659.26K	--

About AstraZeneca PLC

LSE:AZN UK Drug Manufacturers - General

Market Cap

$2.27 Billion

GBX18.67 Trillion GBX

Market Cap Rank

#5743 Global

#12 in UK

Share Price

GBX12036.00

Change (1 day)

+2.52%

52-Week Range

GBX10922.00 - GBX15542.00

All Time High

GBX15542.00